A prospective observational study on efficacy and relapse prevention markers in repetitive transcranial magnetic stimulation therapy for depressio
Not Applicable
Recruiting
- Conditions
- Major depressive disorder
- Registration Number
- JPRN-UMIN000043768
- Lead Sponsor
- Department of Neuropsychiatry, Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Implanted electronic devices/magnetic material Claustrophobia Subjects who are judged as unsuitable for participation in this study by medical doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie rTMS efficacy in major depressive disorder relapse prevention?
How does rTMS compare to SSRIs in preventing relapse for treatment-resistant depression?
Which biomarkers predict response to rTMS therapy in major depressive disorder patients?
What are the long-term adverse events associated with repetitive transcranial magnetic stimulation for depression?
Are there combination therapies with rTMS showing enhanced outcomes for major depressive disorder?